Skip to main content

Table 1 Characteristics of levofloxacin-treated patients with ≥1 isolate of Enterobacteriaceae identified at baseline (mMITT population)

From: Outcomes of high-dose levofloxacin therapy remain bound to the levofloxacin minimum inhibitory concentration in complicated urinary tract infections

Characteristic Levofloxacin N = 370
Age, years
 Mean (SD) 48.0 (20.26)
 Range, n (%) 18–87
  ≥ 65–< 75 47 (12.7)
  ≥ 75 43 (11.6)
Sex, n (%)
 Male 82 (22.2)
 Female 288 (77.8)
Race, n (%)
 White 317 (85.7)
 Black or African American 6 (1.6)
 Asian 30 (8.1)
 Other 17 (4.6)
Region, n (%)
 Eastern Europe 277 (74.9)
 Western Europe 0
 North America 9 (2.4)
 South America 39 (10.5)
 Rest of world 45 (12.2)
Diagnosis, n (%)
 Pyelonephritis 306 (82.7)
 cLUTI 64 (17.3)
Creatinine clearance, mL/min, n (%)
 Normal (≥80) 250 (67.6)
 Mild impairment (≥50–< 80) 92 (24.9)
 Moderate impairment (≥30–< 50) 27 (7.3)
 Severe impairment (<30) 1 (0.3)
  1. cLUTI complicated lower urinary tract infection, mMITT microbiological modified intent-to-treat, SD standard deviation